Robert B. Lobell

2.7k total citations
30 papers, 1.4k citations indexed

About

Robert B. Lobell is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Robert B. Lobell has authored 30 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 14 papers in Oncology and 8 papers in Organic Chemistry. Recurrent topics in Robert B. Lobell's work include Protein Kinase Regulation and GTPase Signaling (11 papers), Cancer-related Molecular Pathways (8 papers) and Click Chemistry and Applications (7 papers). Robert B. Lobell is often cited by papers focused on Protein Kinase Regulation and GTPase Signaling (11 papers), Cancer-related Molecular Pathways (8 papers) and Click Chemistry and Applications (7 papers). Robert B. Lobell collaborates with scholars based in United States, China and Canada. Robert B. Lobell's co-authors include Robert Schleif, John T. Lis, Robert L. Glaser, Claudia A. Sutton, Jeffrey A. Simon, Nancy E. Kohl, Joseph P. Davide, Weikang Tao, Laura Sepp‐Lorenzino and Victoria J. South and has published in prestigious journals such as Science, Cell and Journal of Biological Chemistry.

In The Last Decade

Robert B. Lobell

30 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert B. Lobell United States 18 991 263 258 236 232 30 1.4k
Robin A. Weinberg United States 15 802 0.8× 140 0.5× 204 0.8× 157 0.7× 122 0.5× 19 1.2k
Dirk Eberhard Germany 15 1.5k 1.5× 173 0.7× 163 0.6× 145 0.6× 132 0.6× 19 2.1k
Terence P. Keenan United States 15 1.3k 1.3× 240 0.9× 305 1.2× 331 1.4× 379 1.6× 25 1.7k
Cecilia Chiu United States 16 1.1k 1.2× 87 0.3× 315 1.2× 255 1.1× 309 1.3× 19 1.7k
Toshiro Hamamoto Japan 27 1.7k 1.7× 248 0.9× 122 0.5× 126 0.5× 253 1.1× 68 2.0k
Erwin Schreiner Austria 17 1.9k 1.9× 239 0.9× 276 1.1× 206 0.9× 575 2.5× 35 2.4k
Y. Muto Japan 26 2.1k 2.1× 150 0.6× 178 0.7× 154 0.7× 117 0.5× 92 2.3k
Christopher A. Pargellis United States 13 859 0.9× 71 0.3× 185 0.7× 194 0.8× 208 0.9× 17 1.1k
Joshua M. Gilmore United States 25 1.6k 1.6× 108 0.4× 340 1.3× 151 0.6× 311 1.3× 38 2.1k
S. Gräslund Sweden 21 1.1k 1.1× 100 0.4× 125 0.5× 126 0.5× 100 0.4× 43 1.5k

Countries citing papers authored by Robert B. Lobell

Since Specialization
Citations

This map shows the geographic impact of Robert B. Lobell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert B. Lobell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert B. Lobell more than expected).

Fields of papers citing papers by Robert B. Lobell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert B. Lobell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert B. Lobell. The network helps show where Robert B. Lobell may publish in the future.

Co-authorship network of co-authors of Robert B. Lobell

This figure shows the co-authorship network connecting the top 25 collaborators of Robert B. Lobell. A scholar is included among the top collaborators of Robert B. Lobell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert B. Lobell. Robert B. Lobell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dudkin, Vadim, Cheng Wang, Kenneth L. Arrington, et al.. (2012). Pyridyl aminothiazoles as potent Chk1 inhibitors: Optimization of cellular activity. Bioorganic & Medicinal Chemistry Letters. 22(7). 2613–2619. 6 indexed citations
2.
Liu, Yinhui, Hongmei Wang, Hao Wu, et al.. (2009). Design, synthesis, and evaluation of novel 3-amino-4-hydrazine-cyclobut-3-ene-1,2-diones as potent and selective CXCR2 chemokine receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 19(19). 5741–5745. 13 indexed citations
3.
Roecker, Anthony J., Paul J. Coleman, Swati P. Mercer, et al.. (2007). Kinesin spindle protein (KSP) inhibitors. Part 8: Design and synthesis of 1,4-diaryl-4,5-dihydropyrazoles as potent inhibitors of the mitotic kinesin KSP. Bioorganic & Medicinal Chemistry Letters. 17(20). 5677–5682. 35 indexed citations
4.
5.
Tao, Weikang, Victoria J. South, Yun Zhang, et al.. (2005). Induction of apoptosis by an inhibitor of the mitotic kinesin KSP requires both activation of the spindle assembly checkpoint and mitotic slippage. Cancer Cell. 8(1). 49–59. 228 indexed citations
6.
Dinsmore, Christopher J., C. Blair Zartman, Jeffrey M. Bergman, et al.. (2004). Macrocyclic piperazinones as potent dual inhibitors of farnesyltransferase and geranylgeranyltransferase-I. Bioorganic & Medicinal Chemistry Letters. 14(3). 639–643. 8 indexed citations
7.
Lobell, Robert B., Joseph P. Davide, Nancy E. Kohl, et al.. (2003). A Cell-Based Radioligand Binding Assay for Farnesyl: Protein Transferase Inhibitors. SLAS DISCOVERY. 8(4). 430–438. 1 indexed citations
8.
Tucker, Thomas J., Marc Abrams, Carolyn A. Buser, et al.. (2002). The synthesis and biological evaluation of a series of potent dual inhibitors of farnesyl and geranyl-Geranyl protein transferases. Bioorganic & Medicinal Chemistry Letters. 12(15). 2027–2030. 13 indexed citations
9.
Bergman, Jeffrey M., Donna Wei, C. Blair Zartman, et al.. (2001). Oxo-piperazine Derivatives of N-Arylpiperazinones as Inhibitors of Farnesyltransferase. Bioorganic & Medicinal Chemistry Letters. 11(4). 537–540. 22 indexed citations
10.
Huber, Hans E., R. Robinson, Deborah D. Nahas, et al.. (2001). Anions Modulate the Potency of Geranylgeranyl-Protein Transferase I Inhibitors. Journal of Biological Chemistry. 276(27). 24457–24465. 16 indexed citations
11.
Bergman, Jeffrey M., Marc Abrams, Joseph P. Davide, et al.. (2001). Aryloxy substituted N-arylpiperazinones as dual inhibitors of farnesyltransferase and geranylgeranyltransferase-I. Bioorganic & Medicinal Chemistry Letters. 11(11). 1411–1415. 25 indexed citations
12.
Britten, Carolyn D., Eric K. Rowinsky, Steven L. Soignet, et al.. (2001). A phase I and pharmacological study of the farnesyl protein transferase inhibitor L-778,123 in patients with solid malignancies.. PubMed. 7(12). 3894–903. 65 indexed citations
13.
O’Neill, Timothy J., Dongming Liu, Elaine Rands, et al.. (1999). Imidazole-containing diarylether and diarylsulfone inhibitors of farnesyl-protein transferase. Bioorganic & Medicinal Chemistry Letters. 9(23). 3301–3306. 62 indexed citations
14.
Lobell, Robert B., et al.. (1998). Pre-clinical development of farnesyltransferase inhibitors. Cancer and Metastasis Reviews. 17(2). 203–210. 27 indexed citations
15.
Lobell, Robert B.. (1998). Prenylation of Ras GTPase Superfamily Proteins and Their Function in Immunobiology. Advances in immunology. 68. 145–189. 11 indexed citations
16.
Anthony, Neville J., Carolyn Buser‐Doepner, Anne L. Burkhardt, et al.. (1997). Farnesyl: proteintransferase inhibitors as agents to inhibit tumor growth. BioFactors. 6(3). 359–366. 8 indexed citations
17.
Nocka, Karl, et al.. (1997). Increased Growth Promoting But Not Mast Cell Degranulation Potential of a Covalent Dimer of c-Kit Ligand. Blood. 90(10). 3874–3883. 13 indexed citations
18.
Katz, Howard R. & Robert B. Lobell. (1995). Expression and Function of FcγR in Mouse Mast Cells. International Archives of Allergy and Immunology. 107(1-3). 76–78. 17 indexed citations
19.
Lobell, Robert B. & Robert Schleif. (1991). AraC-DNA looping: Orientation and distance-dependent loop breaking by the cyclic AMP receptor protein. Journal of Molecular Biology. 218(1). 45–54. 72 indexed citations
20.
Lobell, Robert B. & Robert Schleif. (1990). DNA Looping and Unlooping by AraC Protein. Science. 250(4980). 528–532. 203 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Robin A. Weinberg Breakdown of academic impact, for papers by Dirk Eberhard Breakdown of academic impact, for papers by Terence P. Keenan Breakdown of academic impact, for papers by Cecilia Chiu Breakdown of academic impact, for papers by Toshiro Hamamoto Breakdown of academic impact, for papers by Erwin Schreiner Breakdown of academic impact, for papers by Y. Muto Breakdown of academic impact, for papers by Christopher A. Pargellis Breakdown of academic impact, for papers by Joshua M. Gilmore Breakdown of academic impact, for papers by S. Gräslund
Rankless by CCL
2026